Diane Marie Del Valle

13PUBLICATIONS
218CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 03, 2026
TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how.

Yohei Nose, Igor Figueiredo, Kevin Tuballes

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Feb 26, 2025
Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Vladimir Roudko, Diane Marie Del Valle, Emir Radkevich

|Dec 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis.

Joan Shang, Diane Marie Del Valle, Graham J Britton

|Jun 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma.

Edgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede

Pageof 3

Frequent Collaborators

10 joint publications

Sacha Gnjatic

6 joint publications

Edgar Gonzalez-Kozlova

5 joint publications

Ryan Thompson

4 joint publications

Alexander W Charney